Solesence, Inc.
SLSN Consumer Defensive Household & Personal Products
Solesence, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.1 million, up 18.6% from fiscal 2024. In the quarter to June 2026, revenue fell 24.7%, EPS fell 105.5%, free cash flow grew 86.5% and total debt rose 36.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow SLSN
Solesence, Inc. (SLSN) Piotroski F-score
Solesence, Inc.'s Piotroski F-score for fiscal 2025 is 2 out of 9: 2 of nine tests of profitability, leverage and efficiency passed, down from 7 in fiscal 2024.
Piotroski F-score, annual
Embed this chart
Annual newest first
| Period | Piotroski F-score | Change (points) |
|---|---|---|
| FY2025 | 2 | (5.00) |
| FY2024 | 7 | 6.00 |
| FY2023 | 1 | 0.00 |
| FY2022 | 1 | (5.00) |
| FY2021 | 6 | 2.00 |
| FY2020 | 4 | 2.00 |
| FY2019 | 2 | 1.00 |
| FY2018 | 1 | (1.00) |
| FY2017 | 2 | (1.00) |
| FY2016 | 3 | — |
How fiscal 2025’s score is made up
| Test | This year | Year before | Result | Points |
|---|---|---|---|---|
| Positive return on assets | 3.58% | 10.22% | Pass | 1 |
| Positive operating cash flow | (8.57m) | 1.97m | Fail | 0 |
| Rising return on assets | 3.58% | 10.22% | Fail | 0 |
| Cash flow above net income | (10.36m) | (2.26m) | Fail | 0 |
| Falling long-term leverage | 0.21 | 0.00 | Fail | 0 |
| Rising current ratio | 2.07 | 1.14 | Pass | 1 |
| No new shares issued | 70,344,000 | 62,350,000 | Fail | 0 |
| Rising gross margin | 25.88% | 30.92% | Fail | 0 |
| Rising asset turnover | 1.24 | 1.26 | Fail | 0 |
| Piotroski F-score | Weak — most fundamentals deteriorated | 2 | ||
How the Piotroski F-score works
One point for each of nine tests, this fiscal year against the one before: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, a rising current ratio, no new shares issued, a rising gross margin and rising asset turnover. The ratios are the ones on this site, so each can be checked.
Joseph Piotroski (2000) called 8–9 high and 0–1 low; reading it in three bands is the common convention:
| 7–9 | Strong — most fundamentals improved |
|---|---|
| 4–6 | Mixed |
| 0–3 | Weak — most fundamentals deteriorated |
Where this differs from the paper: return on assets is on average rather than beginning-of-year assets, and weighted basic shares stand in for shares issued. The score is shown only when all nine tests can be worked out, which takes three fiscal years; banks and insurers, which report no current assets or gross profit, have none.
Piotroski F-score against peers
| Company | Piotroski F-score |
|---|---|
| NUS Nu Skin Enterprises, Inc. compare | 7 |
| SKIN SkinHealth Systems Inc. compare | 6 |
| ACU Acme United Corporation. compare | 6 |
| UG United-Guardian, Inc. compare | 5 |
| YSG Yatsen Holding Limited Sponsored ADR compare | 5 |
| MLKMF Waldencast PLC compare | 3 |
| GROV Grove Collaborative Holdings, Inc. compare | 3 |
| SLSN Solesence, Inc. | 2 |
| DSY Big Tree Cloud Holdings Limited compare | 2 |
What Piotroski F-score is
The Piotroski F-Score tells an investor how many signs of improving profitability, funding and efficiency a company shows against a year earlier.
One point for each of nine tests against a year earlier: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, rising current ratio, no new shares issued, rising gross margin, and rising asset turnover